Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conbercept for Refractory Uveitic Macular Edema
NCT04296838Phase 3Terminated
- Sponsor
- Peking Union Medical College Hospital
- Start
- Oct 2019
- Primary completion
- Apr 2020
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of conbercept in uveitic macular edema (UME), sponsored by Peking Union Medical College Hospital. Started Oct 2019; status: terminated.
02
Drugs
conbercept
03
Conditions
uveitic macular edema (UME)
Beyond the preview
Go deeper on NCT04296838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04296838.